Gene · 389
Papers2,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New insights into the mechanisms underlying 5-fluorouracil-induced intestinal toxicity based on transcriptomic and metabolomic responses in human intestinal organoids. | Arch Toxicol | 2021 | 34151400 | PubTator, text mining | PubMed |
| Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma. | Front Genet | 2021 | 34149814 | PubTator, text mining | PubMed |
| Glucocorticoid-mediated induction of caveolin-1 disrupts cytoskeletal organization, inhibits cell migration and re-epithelialization of non-healing wounds. | Commun Biol | 2021 | 34145387 | PubTator, text mining | PubMed |
| Identification of Epithelial-Mesenchymal Transition-Related Prognostic lncRNAs Biomarkers Associated With Melanoma Microenvironment. | Front Cell Dev Biol | 2021 | 34136488 | PubTator, text mining | PubMed |
| Prognostic Prediction of Cytogenetically Normal Acute Myeloid Leukemia Based on a Gene Expression Model. | Front Oncol | 2021 | 34123815 | PubTator, text mining | PubMed |
| Early prediction of COVID-19 severity using extracellular vesicle COPB2. | J Extracell Vesicles | 2021 | 34122778 | PubTator, text mining | PubMed |
| Role of a metastatic suppressor gene KAI1/CD82 in the diagnosis and prognosis of breast cancer. | Saudi J Biol Sci | 2021 | 34121877 | PubTator, text mining | PubMed |
| Geranylgeraniol prevents zoledronic acid-mediated reduction of viable mesenchymal stem cells via induction of Rho-dependent YAP activation. | R Soc Open Sci | 2021 | 34113452 | PubTator, text mining | PubMed |
| Development of next-generation tumor-homing induced neural stem cells to enhance treatment of metastatic cancers. | Sci Adv | 2021 | 34108203 | PubTator, text mining | PubMed |
| Identification of Differentially Expressed circRNAs, miRNAs, and Genes in Patients Associated with Cartilaginous Endplate Degeneration. | Biomed Res Int | 2021 | 34104646 | PubTator, text mining | PubMed |
| New possible silver lining for pancreatic cancer therapy: Hydrogen sulfide and its donors. | Acta Pharm Sin B | 2021 | 34094825 | PubTator, text mining | PubMed |
| High Expression of RhoBTB3 Predicts Favorable Chemothrapy Outcomes in non-M3 Acute Myeloid Leukemia. | J Cancer | 2021 | 34093823 | PubTator, text mining | PubMed |
| GTPBP2 positively regulates the invasion, migration and proliferation of non-small cell lung cancer. | J Cancer | 2021 | 34093790 | PubTator, text mining | PubMed |
| Binding between ROCK1 and DCTN2 triggers diabetes‑associated centrosome amplification in colon cancer cells. | Oncol Rep | 2021 | 34080666 | PubTator, text mining | PubMed |
| Rac1, A Potential Target for Tumor Therapy. | Front Oncol | 2021 | 34079763 | PubTator, text mining | PubMed |
| Current Knowledge of Long Non-Coding RNA HOTAIR in Breast Cancer Progression and Its Application. | Life (Basel) | 2021 | 34073224 | PubTator, text mining | PubMed |
| Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis. | Int J Mol Sci | 2021 | 34073119 | PubTator, text mining | PubMed |
| Current Implications of microRNAs in Genome Stability and Stress Responses of Ovarian Cancer. | Cancers (Basel) | 2021 | 34072593 | PubTator, text mining | PubMed |
| MicroRNA Therapeutics in Cancer: Current Advances and Challenges. | Cancers (Basel) | 2021 | 34072348 | PubTator, text mining | PubMed |
| The Crossroads between RAS and RHO Signaling Pathways in Cellular Transformation, Motility and Contraction. | Genes (Basel) | 2021 | 34071831 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389/papers?page=30